FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097041 [Registered on: 07/11/2025] Trial Registered Prospectively
Last Modified On: 30/08/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing two medications with local anaesthetic for pain relief in patients undergoing upperlimb surgeries with the help of ultrasound guided nerve block. 
Scientific Title of Study   A comparative study between dexmedetomidine and dexamethasone as adjuvants to 0.5 percent ropivacaine in ultrasound guided supraclavicular brachial plexus block. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Harshitha N G 
Designation  Junior resident 
Affiliation  Sapthagiri Institute Of Medical Sciences 
Address  Department of Anaesthesiology Sapthagiri Institute of Medical Sciences and Research Centre Navy Layout, Hessaragatta main road, Chikkabanavara, Banglore ,Karnataka

Bangalore
KARNATAKA
560090
India 
Phone  9591869202  
Fax    
Email  harshithang444@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anand Tipanna Talikoti 
Designation  Professor 
Affiliation  Sapthagiri Institute Of Medical Sciences and Research Centre 
Address  Department of Anaesthesiology Sapthagiri Institute of Medical Sciences and Research Centre Navy Layout, Hessaragatta main road, Chikkabanavara, Banglore ,Karnataka

Bangalore
KARNATAKA
560090
India 
Phone  9986093837  
Fax    
Email  drttanand@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anand Tipanna Talikoti 
Designation  Professor 
Affiliation  Sapthagiri Institute Of Medical Sciences and Research Centre 
Address  Department of Anaesthesiology Sapthagiri Institute of Medical Sciences and Research Centre Navy Layout, Hessaragatta main road, Chikkabanavara, Banglore ,Karnataka

Bangalore
KARNATAKA
560090
India 
Phone  9986093837  
Fax    
Email  drttanand@yahoo.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology Sapthagiri Institute of Medical Sciences and Research Centre Navy Layout, Hessaragatta main road, Chikkabanavara, Banglore ,Karnataka,India 560090 
 
Primary Sponsor  
Name  Sapthagiri Institute of Medical Sciences and REsearch Centre 
Address  Department of Anaesthesiology Sapthagiri Institute of Medical Sciences and Research Centre Navy Layout, Hessaragatta main road, Chikkabanavara, Banglore ,Karnataka,India 560090 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Harshitha N G   Sapthagiri Institute of Medical Sciences and Research Centre  Navy Layout, Hessaragatta main road, Chikkabanavara, Banglore ,Karnataka,India 560090
Bangalore
KARNATAKA 
9591869202

harshithang444@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sapthagiri Institute Of Medical Sciences and Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dexamethasone  Pateint allocated in group B will receive 8mg of Dexamethasone as an adjuvant to 0.5 percent Ropivacaine in ultra sound gudided supraclavicular brachial plexus block. 
Comparator Agent  Dexmedetomidine  Pateint allocated in group A will receive 50mcg of Dexmedetomidine as an adjuvant to 0.5 percent Ropivacaine in ultra sound gudided supraclavicular brachial plexus block. 
Intervention  Ultrasound guided supraclavicular brachial plexus block  Using ultrasound guided technique supraclavicular brachial plexus block will be performed using linear probe in plane approach. Patient will be made to lie in supine position and brachial plexus will be visualized using real time visualization of artery, first rib, hypoechoic nodules.After identification of brachial plexus,under aseptic precautions using 22G needle block is performed. Group A will receive: Inj.Ropivacaine 0.5percent30ml and Inj.Dexmedetomidine 50mcg and INJ Normal saline 1.5ml. Group B will receive : Inj.Ropivacaine 0.5percent 30ml and Inj Dexamethasone 8mg 2ml. Assessment done every 5mins for first 30mins thereafter 10mins for 2hrs and every 30mins till the end of surgery.Postoperatively sensory and motor block assessement and vital parameters will be recorded at 10mins 30mins and 1, 2, 4 ,6, 12 and 24hours after the surgery.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details 
1.Patients undergoing unilateral upper limb surgeries.
2.Patient willing to give informed consent.
3.Age between 18yrs to 60yrs.
4.ASA-PS 1 and 2.
5.Weight more than 60kgs
 
 
ExclusionCriteria 
Details  1.Patients refusal.
2.Allergy to local anesthetics and study drugs.
3.Local infections.
4.Bleeding disorders.
5.Patient with neurological psychiatric and neruormuscular disorders.
6.Patient with history of hepatic, renal, cardiopulmonary abnormalities.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1)Onset and duration of sensory block
2)Onset and duration of motor block
3)Time of rescue anlagesia
 
Every 5mins for first 30mins thereafter 10mins for 2hrs and every 30mins till the end of surgery.Postoperatively sensory and motor block assessement will be recorded at 10mins 30mins and 1, 2, 4 ,6, 12 and 24hours after the surgery.
 
 
Secondary Outcome  
Outcome  TimePoints 
Nil   
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Patients fulfilling the inclusion criteria and posted for upper limb surgeries will be assigned to either group A and group B through a computer-generated random numbers, maintaining a equal ratio. Group A patients will receive 30 ml of 0.5 percent Ropivacaine with Dexmedetomidine 50micrograms and Group B will receive 30 ml of 0.5 percent Ropivacaine with 8milligram of Dexamethasone. Under Ultrasound guidance supraclavicular  brachial plexus block will be given, onset of sensory and motor block will be noted. Duration of sensory and motor block will be assessed 5mins for first 30mins thereafter 10mins for 2hrs and every 30mins till the end of surgery. Post-operatively, sensory and motor blockade and  vital parameters will  be recorded at 10mins 30mins and 1, 2, 4 ,6, 12 and 24hours after the surgery.The block will be considered incomplete when any of the segments supplied by median, radial, ulnar and musculocutaneous nerve did not have analgesia even after 30min of drug injection. Then such patients will be converted to general anaesthesia and will be excluded from the study. There is limited literature available comparing Dexmedetomidine and Dexamethasone as an adjuvant to ropivacaine in supraclavicular brachial plexus block. Hence, the present study will be undertaken to compare the efficacy of Dexmedetomidine and Dexamethasone as an adjuvant to ropivacaine in supraclavicular brachial plexus block in terms of onset and duration of sensory and motor block and duration of post operative analgesia. 
Close